About Anushka Mukherjee
Anushka's fascination with the stock market and its intricacies began during her time as an equity research intern after graduating with a bachelor's degree in commerce.
To kickstart her professional journey, she embarked on the role of an Investment Analyst while concurrently pursuing the CFA program.
Anushka's ultimate aim is to equip investors with essential knowledge that empowers them to make well-informed investment choices and attain sustained financial prosperity in the long run.
Recent Articles By Anushka Mukherjee
Morgan Stanley (MS) Prepares for Earnings Report - Is Now the Time to Buy, Hold, or Sell?
Morgan Stanley (MS) is all set to disclose its fiscal first-quarter earnings on April 16. However, with the company facing intense scrutiny from multiple federal agencies, should investors consider owning its shares? Keep reading to find out…
PNC Financial (PNC) Earnings on the Horizon - Buy or Sell?
PNC Financial Services (PNC) is navigating a challenging landscape, which is evident from its underwhelming fourth-quarter performance due to regulatory charges and expenses related to layoffs. Given this outlook, would it be a wise move to invest in the company’s shares ahead of its fiscal 2024 first-quarter earnings? Read more to find out…
3 China Stocks Positioned for Long-Term Growth
Despite facing challenges, the Chinese economy has demonstrated resilience, as evidenced by recent robust industrial output and retail sales data. Given this outlook, it might be an opportune time to own three top-notch China stocks, JD.com, Inc. (JD), China Automotive Systems (CAAS), and Youdao, Inc. (DAO). Read on…
Will Walgreens (WBA) Earnings Present Prime Investment Opportunities?
Over the recent months, pharmaceutical retailer Walgreens Boots Alliance (WBA) has witnessed a major drop in its shares as a result of announcing dividend cuts and losing its spot among the top 30 blue chip companies. However, with the company’s fiscal second results on the horizon, should investors be keen on acquiring the company’s shares at this juncture? Read more to find out…
Is SAIC Worth Buying, Holding, or Selling Post-Earnings?
Despite Science Applications International Corp's (SAIC) commitment to enhancing shareholder value and securing major contracts in recent months, the company experienced a decline in its share price due to its underwhelming financial performance. That being said, what stance should investors take in light of these developments? Read more to find out…
Adobe (ADBE) Pre-Earnings Review: Is it Time to Invest?
Adobe Inc. (ADBE) is all set to announce its fiscal first-quarter earnings on March 14. With the company launching a slew of AI integrated products, all aimed at riding the wave of prevailing AI frenzy, would it be an opportune time to own the shares of this software giant? Keep reading to find out…
Anticipating ORCL Earnings: Is Oracle a Buy?
Since the dawn of groundbreaking generative AI platforms, software titan Oracle Corp (ORCL) has surged forward, rapidly expanding its cloud and generative AI services to challenge industry frontrunners. Given this outlook, with the company’s fiscal 2024 third-quarter earnings on the horizon, would it be wise to invest in this stock? Read more to find out…
DOCU Pre-Earnings Watch: Is There Potential Upside?
DocuSign (DOCU) is poised to unveil its fiscal 2024 fourth-quarter earnings on March 7. With a solid track record of surpassing analyst estimates and its bold strategic restructuring initiatives aimed at fortifying its operational efficiency, could owning DOCU’s shares be a potentially lucrative opportunity for investors ahead of its earnings? Keep reading to find out…
AI Stocks MSFT and NVDA: Evaluating Buy, Hold, or Sell for March
AI stands out as one of the most disruptive innovations, gaining increasing prominence as it revolutionizes numerous industries with its transformative capabilities. In such a scenario, let’s assess the fundamentals of two key players in this space, Microsoft (MSFT) and NVIDIA Corp (NVDA) to determine if they are a buy, hold, or sell for March. Read on…